(Alliance News) - Oxford BioMedica PLC on Monday said it expects to report a jump in revenue in the first half of the year as its order book more than doubled. Read More
(Alliance News) - Oxford BioMedica PLC on Monday said it has completed the acquisition of the remaining 10% stake in its US subsidiary from Massachusetts, US-based biotechnology firm Q32 Bio Inc. Read More
(Alliance News) - Oxford BioMedica PLC reported "strong commercial momentum" during the first half of the year, in a statement ahead of its annual general meeting on Wednesday. Read More
(Alliance News) - Oxford BioMedica PLC on Wednesday said its client portfolio continued to expand and diversify, noting it was on track to achieve "significant" revenue growth consistent with medium-term guidance. Read More
(Alliance News) - London's FTSE 100 is called to open lower on Wednesday following the announcement of new further US tariffs on China, and global markets brace themselves for further turmoil. Read More
(Alliance News) - Oxford BioMedica PLC on Monday said it was confident of delivering "another year of strong progress," noting strength of demand. Read More
